Back to Article
Clinical differences between hospitalized patients with COVID-19-related pneumonia and those with influenza-related pneumonia during the omicron variant surge
Global Journal of Epidemiology and Infectious Disease
| Vol 4, Issue 1
Table 2. Pneumonia conditions and findings by group
| COVID-19 pneumonia | Flu pneumonia | p value | |
| Symptoms | |||
| Fever | 30 (65.2%) | 6 (100%) | 0.082 |
| Dyspnea | 11 (23.9%) | 3 (50.0%) | 0.175 |
| Nausea, vomitting | 5 (10.9%) | 0 | 0.396 |
| General malaise | 3 (6.5%) | 4 (66.7%) | <0.001** |
| Low conciousness | 2 (4.3%) | 0 | 0.602 |
| Cough | 2 (4.3%) | 1 (2.2%) | 0.223 |
| Palpitation | 1 (2.2%) | 0 | 0.715 |
| None | 1 (2.2%) | 0 | 0.715 |
| Severity | |||
| Mild | 9 (19.6%) | 2 (33.3%) | 0.474 |
| Moderate | 31 (67.4%) | 2 (33.3%) | 0.103 |
| Severe | 6 (13.4%) | 2 (33.3%) | 0.806 |
| Bacteria | |||
| MSSA | 1 (2.2%) | 1 (16.7%) | 0.082 |
| MSSA | 1 (2.2%) | 1 (16.7%) | 0.082 |
| GAS | 0 | 1 (16.7%) | 0.005** |
| MRCNS | 1 (2.2%) | 0 | 0.715 |
| E coli | 1 (2.2%) | 0 | 0.715 |
| Klebsiella spp | 1 (2.2%) | 0 | 0.715 |
| Aspiration pneumonia | 28 (28/46=60.9%) | 1 (1/6=16.7%) | 0.040* |